Organoid Studies in COVID-19 Research

Jihoon Kim, Bon-Kyoung Koo, Hans Clevers

Research output: Contribution to journal/periodicalBook/Film/Article reviewScientific

7 Citations (Scopus)


The current COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has completely changed human life for more than two years. Upon the emergence of this new lethal virus, multiple approaches were utilized to gain basic knowledge about its biology. Moreover, modern technologies, such as the organoid model system and next-generation sequencing, enabled us to rapidly establish strategies to tackle the disease, including vaccines and therapeutics. The recently developed organoid technology reflects human physiology more closely than other model systems. Coupled with its rapidness, high efficiency, and outstanding reliability, it has provided an opportunity to develop new drugs and understand the impact of the viral pathogen on the host. Recent findings using organoids have successfully revealed the cellular tropism of the virus in different organs and identified potential drug candidates that impact the disease. This review will summarize current achievements made with organoids in the fight against COVID-19.

Original languageEnglish
Pages (from-to)3-13
Number of pages11
JournalInternational journal of stem cells
Issue number1
Publication statusPublished - 28 Feb 2022


Dive into the research topics of 'Organoid Studies in COVID-19 Research'. Together they form a unique fingerprint.

Cite this